Pfizer’s Crisaborole ointment, 2% (Eucrisa) for atopic dermatitis is commonly applied by patients in combination with emollients. MedPharm designed and performed a study to determine the potential effect of emollient application on Eucrisa performance. MedPharm used its proprietary MedFlux-HT® automated flow system to determine the penetration of Eucrisa through fresh human skin in the presence and absence of these emollients. MedFlux-HT closely replicated a clinical environment for the study, preventing any drug […]